Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial

Autor: Lewis, James J., Liu, Xiaoqiu, Zhang, Zhiying, Thomas, Bruce V., Vassall, Anna, Sweeney, Sedona, Caihong, Xu, Dongmei, Hu, Xue, Li, Yongxin, Gao, Huan, Shitong, Shiwen, Jiang, Fielding, Katherine L.

Publikováno v: Trials, Vol 19, Iss 1, Pp 1-12 (2018)
Trials

Background Treatment for drug-sensitive tuberculosis (TB) is taken for at least 6 months and problems with adherence are common. Therefore, there is substantial interest in the possible use of eHealth interventions to support patients to take their t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ff63129ea27a4625d57d156904e753cb
http://link.springer.com/article/10.1186/s13063-018-2650-3

Tuberculosis control, and the where and why of artificial intelligence.

Autor: Doshi R; Center for Public Health and Health Policy, University of Connecticut Health Center, Farmington, CT, USA., Falzon D; Global TB Programme, World Health Organization, Geneva, Switzerland., Thomas BV; The Arcady Group, Richmond, VA, USA., Temesgen Z; Mayo Clinic, Rochester, MN, USA., Sadasivan L; PATH, Washington, DC, USA., Migliori GB; WHO Collaborating Centre for TB and Lung Diseases, Maugeri Care and Research Institute, Tradate, Italy., Raviglione M; Global TB Programme, World Health Organization, Geneva, Switzerland.

Publikováno v: ERJ open research [ERJ Open Res] 2017 Jun 21; Vol. 3 (2). Date of Electronic Publication: 2017 Jun 21 (Print Publication: 2017).